Healthcare industry revolves around early accurate diagnosis and cost effective efficacious treatment. Approximately USD 120 billion is spent every year upon research and development of new medicines. Pharmaceutical companies typically spend around USD 1.3 billion to develop a single molecule investing several thousands of scientific hours while encountering numerous challenges to bring innovative medicines into the market.
Our team with several decades of experience in global pharmaceutical research and development, offers services and consultation in early drug discovery, preclinical development and early translational research. We bring insight and strategic planning that help researchers make better and faster decisions. Aravali Pharma has expertise in preparing due diligence reports for validation of therapeutic targets.
We provide services and synthesis of API/intermediates, drug impurities, specialty chemicals and analytical services. Our chemist have decades of experience in synthesis, designing of drugs and analytical chemistry.
Strong Intellectual Property (IP) is crucial to incentivise the high investment made in research and development. Aravali Pharma provides consultancy on a wide spectrum of IP issues to enable clients protect their interest.
Our artificial intelligence tool “Mystic” enables hospitals, diagnostic labs and doctors to diagnose and monitor diseases accurately and precisely. Mystic offers enhanced medical images for accurate diagnosis leading to right treatment at the right time.
With deep domain knowledge and expertise in drug discovery, we offer on-site trainings for budding researchers making them bench and/or industry ready.
"Your trusted partner in mapping the road from early discovery to IND"
